These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32583902)

  • 1. Open-Label, Multi-Dose, Pilot Safety Study of Injection of OnabotulinumtoxinA Toward the Otic Ganglion for the Treatment of Intractable Chronic Cluster Headache.
    Crespi J; Bratbak D; Dodick DW; Matharu M; Solheim O; Gulati S; Berntsen EM; Tronvik E
    Headache; 2020 Sep; 60(8):1632-1643. PubMed ID: 32583902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot Study of Injection of OnabotulinumtoxinA Toward the Sphenopalatine Ganglion for the Treatment of Classical Trigeminal Neuralgia.
    Crespi J; Bratbak D; Dodick DW; Matharu M; Jamtøy KA; Tronvik E
    Headache; 2019 Sep; 59(8):1229-1239. PubMed ID: 31342515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic cluster headache.
    Bratbak DF; Nordgård S; Stovner LJ; Linde M; Folvik M; Bugten V; Tronvik E
    Cephalalgia; 2016 May; 36(6):503-9. PubMed ID: 26232105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic migraine.
    Bratbak DF; Nordgård S; Stovner LJ; Linde M; Dodick DW; Aschehoug I; Folvik M; Tronvik E
    Cephalalgia; 2017 Apr; 37(4):356-364. PubMed ID: 27154997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Outcome of Patients With Intractable Chronic Cluster Headache Treated With Injection of Onabotulinum Toxin A Toward the Sphenopalatine Ganglion - An Observational Study.
    Aschehoug I; Bratbak DF; Tronvik EA
    Headache; 2018 Nov; 58(10):1519-1529. PubMed ID: 30216444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders-A retrospective tolerability and safety study.
    Anderson CC; Iser CR; Hirte IL; Boddu S; Girardo ME; VanderPluym JH; Starling AJ
    Headache; 2024 Jun; 64(6):663-673. PubMed ID: 38700250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OnabotulinumtoxinA injection towards the SPG for treating symptoms of refractory chronic rhinosinusitis with nasal polyposis: a pilot study.
    Jamtøy KA; Tronvik E; Bratbak DF; Crespi J; Stovner LJ; Aschehoug I; Thorstensen WM
    Acta Otolaryngol; 2021 Oct; 141(10):934-940. PubMed ID: 34633904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
    Aurora SK; Winner P; Freeman MC; Spierings EL; Heiring JO; DeGryse RE; VanDenburgh AM; Nolan ME; Turkel CC
    Headache; 2011 Oct; 51(9):1358-73. PubMed ID: 21883197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized Trial to Evaluate OnabotulinumtoxinA for Prevention of Headaches in Adolescents With Chronic Migraine.
    Winner PK; Kabbouche M; Yonker M; Wangsadipura V; Lum A; Brin MF
    Headache; 2020 Mar; 60(3):564-575. PubMed ID: 32037549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type-A therapy in cluster headache: an open study.
    Sostak P; Krause P; Förderreuther S; Reinisch V; Straube A
    J Headache Pain; 2007 Sep; 8(4):236-41. PubMed ID: 17901920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onabotulinumtoxin-A treatment in Greek patients with chronic migraine.
    Vikelis M; Argyriou AA; Dermitzakis EV; Spingos KC; Mitsikostas DD
    J Headache Pain; 2016 Dec; 17(1):84. PubMed ID: 27640152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of sphenopalatine ganglion stimulation for chronic cluster headache: a double-blind, randomised controlled trial.
    Goadsby PJ; Sahai-Srivastava S; Kezirian EJ; Calhoun AH; Matthews DC; McAllister PJ; Costantino PD; Friedman DI; Zuniga JR; Mechtler LL; Popat SR; Rezai AR; Dodick DW
    Lancet Neurol; 2019 Dec; 18(12):1081-1090. PubMed ID: 31701891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine.
    Cady RK; Schreiber CP; Porter JA; Blumenfeld AM; Farmer KU
    Headache; 2011 Jan; 51(1):21-32. PubMed ID: 21070228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study.
    Mathew NT; Jaffri SF
    Headache; 2009; 49(10):1466-78. PubMed ID: 19912346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Efficacy of Botulinum Toxin in Cluster Headache: A Systematic Review.
    Freund B; Kotchetkov IS; Rao A
    J Oral Facial Pain Headache; 2020; 34(2):129–134. PubMed ID: 31560734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with onabotulinumtoxinA (BOTOX) in chronic refractory migraine: focus on severe attacks.
    Oterino A; Ramón C; Pascual J
    J Headache Pain; 2011 Apr; 12(2):235-8. PubMed ID: 21298315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chronic daily headache with comorbid anxiety and depression using botulinum toxin A: a prospective pilot study.
    Zhang H; Zhang H; Wei Y; Lian Y; Chen Y; Zheng Y
    Int J Neurosci; 2017 Apr; 127(4):285-290. PubMed ID: 27439999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OnabotulinumtoxinA for the prophylactic treatment of headaches in adult patients with chronic migraine: a safety evaluation.
    Cheng F; Ahmed F
    Expert Opin Drug Saf; 2021 Nov; 20(11):1275-1289. PubMed ID: 34187265
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical profile of botulinum toxin A in patients with chronic headaches and cervical dystonia: a prospective, open-label, longitudinal study conducted in a naturalistic clinical practice setting.
    Dowson AJ; Kilminster SG; Salt R
    Drugs R D; 2008; 9(3):147-58. PubMed ID: 18457467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphenopalatine Ganglion Pulsed Radiofrequency for the Treatment of Refractory Chronic SUNCT and SUNA: A Prospective Case Series.
    Ornello R; Palmisani S; Murphy M; Sacco S; Al-Kaisy A; Lambru G
    Headache; 2020 May; 60(5):938-945. PubMed ID: 32202666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.